4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-037144
Director sold 3,900 shares at an average $32.55 ($126,935)
- Director acquired 3,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-01 | Exercise or conversion : show line 1 in the form | +1,950 | $2.95 | $5,753 | 1,950 | I |
| 2021-06-01 | Sale : show line 2 in the form | −1,392 | $32.15 | $44,754 | 558 | I |
| 2021-06-01 | Sale : show line 3 in the form | −553 | $33.61 | $18,587 | 5 | I |
| 2021-06-01 | Sale : show line 4 in the form | −5 | $34.67 | $173 | 0 | I |
| 2021-06-01 | Exercise or conversion : show line 5 in the form | +975 | $2.95 | $2,876 | 975 | I |
| 2021-06-01 | Sale : show line 6 in the form | −743 | $32.16 | $23,896 | 232 | I |
| 2021-06-01 | Sale : show line 7 in the form | −230 | $33.75 | $7,762 | 2 | I |
| 2021-06-01 | Sale : show line 8 in the form | −2 | $34.67 | $69 | 0 | I |
| Open-market sales · 3,900 sh · avg $32.55 · $126,935 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-01 | Exercise or conversion : show line 13 in the form Stock Option (right to buy) | −1,950 | 15,901 | I |
| 2021-06-01 | Exercise or conversion : show line 14 in the form Stock Option (right to buy) | −975 | 7,951 | I |
| 2021-06-01 | Exercise or conversion : show line 15 in the form Stock Option (right to buy) | −975 | 7,951 | I |
Loading xslF345X03/doc4.xml…